Condition
Atopic Dermatitis and Related Conditions
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04240522Recruiting
Prospective Longitudinal Observational Research in Atopic Dermatitis
NCT03293030Phase 4Completed
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
NCT06361992Phase 3Completed
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
NCT03619161Not ApplicableCompleted
Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema
Showing all 4 trials